| 000 | 01489 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518043905.0 | ||
| 264 | 0 | _c20200527 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a1879-114X | ||
| 024 | 7 |
_a10.1016/j.clinthera.2019.05.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVisaria, Jay | |
| 245 | 0 | 0 |
_aIncidence and Prevalence of Microvascular and Macrovascular Diseases and All-cause Mortality in Type 2 Diabetes Mellitus: A 10-year Study in a US Commercially Insured and Medicare Advantage Population. _h[electronic resource] |
| 260 |
_bClinical therapeutics _c08 2019 |
||
| 300 |
_a1522-1536.e1 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 650 | 0 | 4 |
_aVascular Diseases _xepidemiology |
| 700 | 1 | _aIyer, Neeraj N | |
| 700 | 1 | _aRaval, Amit | |
| 700 | 1 | _aKong, Sheldon | |
| 700 | 1 | _aHobbs, Todd | |
| 700 | 1 | _aBouchard, Jonathan | |
| 700 | 1 | _aKern, David M | |
| 700 | 1 | _aWilley, Vincent | |
| 773 | 0 |
_tClinical therapeutics _gvol. 41 _gno. 8 _gp. 1522-1536.e1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clinthera.2019.05.012 _zAvailable from publisher's website |
| 999 |
_c29795932 _d29795932 |
||